Sunday, November 3, 2024
HomeDaily Life in DenmarkHealthcareMedicinrådet (Medical Council) recommends the drug Enhertu for patients with the HER2-low...

Medicinrådet (Medical Council) recommends the drug Enhertu for patients with the HER2-low type of breast cancer

-

The Medical Council estimates that Enhertu can extend patients’ lives, although it is very uncertain for how long. At the same time, there are more severe side effects with treatment with Enhertu than with the current treatment. The recommendation of Enhertu for HER2-low comes after the pharmaceutical company lowered the price at the request of the Medical Council. 

Narcis George Matache
Narcis George Matachehttp://www.narcis.dk
Executive Editor and Founder of "Last Week in Denmark".

Related articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Stay connected

Latest posts